BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:37 PM
 | 
May 06, 2010
 |  BC Extra  |  Company News

Intercell acquires Cytos mAb technology

Intercell AG (VSE:ICLL; OTCQX:INRLY) acquired mAb discovery technology for infectious diseases from Cytos Biotechnology Ltd. (SIX:CYTN) for EUR 15 million ($19.9 million). The technology, which is a specific...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >